Bausch Health Companies Inc. (BHC)
USD 5.42
(2.26%)
USD 5.42
(2.26%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 6.19 Billion USD | 7.6% |
| 2022 | 5.76 Billion USD | -4.64% |
| 2021 | 6.04 Billion USD | 4.53% |
| 2020 | 5.77 Billion USD | -7.57% |
| 2019 | 6.25 Billion USD | 3.68% |
| 2018 | 6.02 Billion USD | -2.38% |
| 2017 | 6.17 Billion USD | -12.56% |
| 2016 | 7.06 Billion USD | -10.07% |
| 2015 | 7.85 Billion USD | 30.7% |
| 2014 | 6 Billion USD | 55.49% |
| 2013 | 3.86 Billion USD | 54.08% |
| 2012 | 2.5 Billion USD | 44.42% |
| 2011 | 1.73 Billion USD | 123.94% |
| 2010 | 775.48 Million USD | 56.56% |
| 2009 | 495.33 Million USD | -11.55% |
| 2008 | 560.01 Million USD | -9.55% |
| 2007 | 619.13 Million USD | -26.92% |
| 2006 | 847.2 Million USD | 16.26% |
| 2005 | 728.72 Million USD | 10.91% |
| 2004 | 657.01 Million USD | -3.98% |
| 2003 | 684.26 Million USD | 9.78% |
| 2002 | 623.31 Million USD | 36.31% |
| 2001 | 457.26 Million USD | 89.63% |
| 2000 | 241.13 Million USD | 62.6% |
| 1999 | 148.3 Million USD | 66.26% |
| 1998 | 89.2 Million USD | 63.07% |
| 1997 | 54.7 Million USD | 26.62% |
| 1996 | 43.2 Million USD | 163.41% |
| 1995 | 16.4 Million USD | 26.15% |
| 1994 | 13 Million USD | 44.44% |
| 1993 | 9 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.23 Billion USD | -70.78% |
| 2024 Q2 | 1.41 Billion USD | 14.61% |
| 2024 Q3 | 2.49 Billion USD | 8.38% |
| 2023 Q1 | 1.36 Billion USD | -11.62% |
| 2023 Q2 | 1.51 Billion USD | 11.45% |
| 2023 Q3 | 1.61 Billion USD | 6.39% |
| 2023 FY | 6.19 Billion USD | 7.6% |
| 2023 Q4 | 4.22 Billion USD | 161.42% |
| 2022 Q2 | 1.39 Billion USD | 1.68% |
| 2022 Q3 | 1.46 Billion USD | 5.18% |
| 2022 FY | 5.76 Billion USD | -4.64% |
| 2022 Q4 | 1.54 Billion USD | 5.4% |
| 2022 Q1 | 1.36 Billion USD | -12.93% |
| 2021 Q4 | 1.57 Billion USD | 2.68% |
| 2021 FY | 6.04 Billion USD | 4.53% |
| 2021 Q1 | 1.45 Billion USD | -7.33% |
| 2021 Q3 | 1.52 Billion USD | 2.76% |
| 2021 Q2 | 1.48 Billion USD | 2.41% |
| 2020 Q2 | 1.16 Billion USD | -21.7% |
| 2020 Q4 | 1.56 Billion USD | 1.29% |
| 2020 FY | 5.77 Billion USD | -7.57% |
| 2020 Q1 | 1.49 Billion USD | -6.04% |
| 2020 Q3 | 1.54 Billion USD | 32.42% |
| 2019 Q4 | 1.58 Billion USD | -2.22% |
| 2019 Q3 | 1.62 Billion USD | 4.3% |
| 2019 Q2 | 1.55 Billion USD | 5.34% |
| 2019 Q1 | 1.47 Billion USD | -2.63% |
| 2019 FY | 6.25 Billion USD | 3.68% |
| 2018 FY | 6.02 Billion USD | -2.38% |
| 2018 Q1 | 1.42 Billion USD | -6.2% |
| 2018 Q2 | 1.53 Billion USD | 7.88% |
| 2018 Q3 | 1.55 Billion USD | 1.3% |
| 2018 Q4 | 1.51 Billion USD | -2.25% |
| 2017 Q2 | 1.58 Billion USD | 4.89% |
| 2017 Q3 | 1.56 Billion USD | -1.7% |
| 2017 Q4 | 1.51 Billion USD | -2.82% |
| 2017 FY | 6.17 Billion USD | -12.56% |
| 2017 Q1 | 1.51 Billion USD | -12.95% |
| 2016 Q2 | 1.76 Billion USD | 1.19% |
| 2016 FY | 7.06 Billion USD | -10.07% |
| 2016 Q4 | 1.73 Billion USD | -4.59% |
| 2016 Q3 | 1.82 Billion USD | 3.36% |
| 2016 Q1 | 1.74 Billion USD | -15.11% |
| 2015 FY | 7.85 Billion USD | 30.7% |
| 2015 Q4 | 2.05 Billion USD | -4.06% |
| 2015 Q1 | 1.61 Billion USD | -4.38% |
| 2015 Q2 | 2.04 Billion USD | 26.67% |
| 2015 Q3 | 2.13 Billion USD | 4.46% |
| 2014 Q4 | 1.69 Billion USD | 13.03% |
| 2014 Q1 | 1.36 Billion USD | 2.7% |
| 2014 Q2 | 1.45 Billion USD | 6.41% |
| 2014 FY | 6 Billion USD | 55.49% |
| 2014 Q3 | 1.49 Billion USD | 2.74% |
| 2013 Q4 | 1.33 Billion USD | 37.79% |
| 2013 FY | 3.86 Billion USD | 54.08% |
| 2013 Q3 | 966.52 Million USD | 21.1% |
| 2013 Q2 | 798.12 Million USD | 3.92% |
| 2013 Q1 | 768.02 Million USD | 9.78% |
| 2012 Q2 | 610.32 Million USD | 12.14% |
| 2012 Q4 | 699.63 Million USD | 7.0% |
| 2012 Q1 | 544.26 Million USD | 8.03% |
| 2012 Q3 | 653.88 Million USD | 7.14% |
| 2012 FY | 2.5 Billion USD | 44.42% |
| 2011 Q1 | 361.79 Million USD | 23.16% |
| 2011 Q3 | 434.93 Million USD | -0.26% |
| 2011 Q4 | 503.8 Million USD | 15.83% |
| 2011 FY | 1.73 Billion USD | 123.94% |
| 2011 Q2 | 436.08 Million USD | 20.53% |
| 2010 Q3 | 146.12 Million USD | -16.46% |
| 2010 Q2 | 174.92 Million USD | 8.86% |
| 2010 Q4 | 293.76 Million USD | 101.03% |
| 2010 FY | 775.48 Million USD | 56.56% |
| 2010 Q1 | 160.68 Million USD | -11.86% |
| 2009 Q2 | 143.47 Million USD | 11.67% |
| 2009 FY | 495.33 Million USD | -11.55% |
| 2009 Q1 | 128.47 Million USD | -0.72% |
| 2009 Q4 | 182.31 Million USD | 12.64% |
| 2009 Q3 | 161.85 Million USD | 12.81% |
| 2008 FY | 560.01 Million USD | -9.55% |
| 2008 Q4 | 129.4 Million USD | -3.15% |
| 2008 Q3 | 133.62 Million USD | -6.04% |
| 2008 Q2 | 142.21 Million USD | -8.11% |
| 2008 Q1 | 154.76 Million USD | 9.28% |
| 2007 Q1 | 186.42 Million USD | -26.84% |
| 2007 Q2 | 148.49 Million USD | -20.35% |
| 2007 FY | 619.13 Million USD | -26.92% |
| 2007 Q3 | 138.43 Million USD | -6.78% |
| 2007 Q4 | 141.62 Million USD | 2.31% |
| 2006 FY | 847.2 Million USD | 16.26% |
| 2006 Q4 | 254.8 Million USD | 10.68% |
| 2006 Q3 | 230.22 Million USD | 20.54% |
| 2006 Q2 | 190.98 Million USD | 11.56% |
| 2006 Q1 | 171.19 Million USD | -26.77% |
| 2005 Q3 | 206.06 Million USD | 31.65% |
| 2005 Q4 | 233.76 Million USD | 13.44% |
| 2005 FY | 728.72 Million USD | 10.91% |
| 2005 Q2 | 156.52 Million USD | 17.54% |
| 2005 Q1 | 133.17 Million USD | -37.0% |
| 2004 Q4 | 211.37 Million USD | 28.98% |
| 2004 Q1 | 134.48 Million USD | -9.8% |
| 2004 Q3 | 163.89 Million USD | 11.29% |
| 2004 Q2 | 147.26 Million USD | 9.5% |
| 2004 FY | 657.01 Million USD | -3.98% |
| 2003 Q3 | 175.23 Million USD | -14.91% |
| 2003 FY | 684.26 Million USD | 9.78% |
| 2003 Q1 | 153.97 Million USD | -21.04% |
| 2003 Q4 | 149.1 Million USD | -14.91% |
| 2003 Q2 | 205.95 Million USD | 33.75% |
| 2002 Q3 | 164.93 Million USD | 14.67% |
| 2002 Q1 | 119.53 Million USD | -16.19% |
| 2002 FY | 623.31 Million USD | 36.31% |
| 2002 Q4 | 195 Million USD | 18.23% |
| 2002 Q2 | 143.84 Million USD | 20.33% |
| 2001 Q2 | 105.97 Million USD | 14.35% |
| 2001 FY | 457.26 Million USD | 89.63% |
| 2001 Q1 | 92.67 Million USD | 29.45% |
| 2001 Q4 | 142.63 Million USD | 23.42% |
| 2001 Q3 | 115.56 Million USD | 9.06% |
| 2000 Q4 | 71.58 Million USD | -6.79% |
| 2000 Q3 | 76.8 Million USD | 49.47% |
| 2000 Q1 | 41.36 Million USD | -24.93% |
| 2000 FY | 241.13 Million USD | 62.6% |
| 2000 Q2 | 51.38 Million USD | 24.22% |
| 1999 Q2 | 30 Million USD | 21.46% |
| 1999 Q1 | 24.7 Million USD | -13.64% |
| 1999 Q3 | 38.5 Million USD | 28.33% |
| 1999 Q4 | 55.1 Million USD | 43.12% |
| 1999 FY | 148.3 Million USD | 66.26% |
| 1998 Q2 | 19.5 Million USD | 8.94% |
| 1998 Q4 | 28.6 Million USD | 22.75% |
| 1998 FY | 89.2 Million USD | 63.07% |
| 1998 Q1 | 17.9 Million USD | 138.67% |
| 1998 Q3 | 23.3 Million USD | 19.49% |
| 1997 Q3 | 19.1 Million USD | 30.82% |
| 1997 FY | 54.7 Million USD | 26.62% |
| 1997 Q2 | 14.6 Million USD | 18.7% |
| 1997 Q1 | 12.3 Million USD | 26.8% |
| 1997 Q4 | 7.5 Million USD | -60.73% |
| 1996 Q4 | 9.7 Million USD | -14.91% |
| 1996 Q1 | 11 Million USD | 19.57% |
| 1996 FY | 43.2 Million USD | 163.41% |
| 1996 Q2 | 11.6 Million USD | 5.45% |
| 1996 Q3 | 11.4 Million USD | -1.72% |
| 1995 Q2 | 2.6 Million USD | -39.53% |
| 1995 Q1 | 4.3 Million USD | -15.69% |
| 1995 Q3 | 3 Million USD | 15.38% |
| 1995 Q4 | 9.2 Million USD | 206.67% |
| 1995 FY | 16.4 Million USD | 26.15% |
| 1994 Q4 | 5.1 Million USD | -3.77% |
| 1994 Q1 | 2.5 Million USD | 0.0% |
| 1994 Q2 | 1.3 Million USD | -48.0% |
| 1994 Q3 | 5.3 Million USD | 307.69% |
| 1994 FY | 13 Million USD | 44.44% |
| 1993 FY | 9 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 820.56 Million USD | -655.333% |
| Catalent, Inc. | 953 Million USD | -550.367% |
| Emergent BioSolutions Inc. | 343.9 Million USD | -1702.268% |
| Elanco Animal Health Incorporated | 2.48 Billion USD | -149.316% |
| Perrigo Company plc | 1.68 Billion USD | -268.841% |
| Teva Pharmaceutical Industries Limited | 7.64 Billion USD | 18.938% |
| Zoetis Inc. | 5.83 Billion USD | -6.239% |